MARKET

AUPH

AUPH

Aurinia Pharmace
NASDAQ
17.55
-1.07
-5.75%
After Hours: 17.80 +0.25 +1.42% 18:59 06/25 EDT
OPEN
18.72
PREV CLOSE
18.62
HIGH
18.92
LOW
17.47
VOLUME
2.15M
TURNOVER
--
52 WEEK HIGH
19.25
52 WEEK LOW
7.29
MARKET CAP
2.26B
P/E (TTM)
8.10
1D
5D
1M
3M
1Y
5Y
1D
5 Small Drug Stocks to Invest in Amid a Biotech Comeback
NASDAQ · 13h ago
Aurinia (AUPH) Moves 6.5% Higher: Will This Strength Last?
NASDAQ · 2d ago
Weekly Report: what happened at AUPH last week (0615-0619)?
Weekly Report · 3d ago
Weekly Report: what happened at AUPH last week (0608-0612)?
Weekly Report · 06/15 09:51
13D Filings
Barron‘s · 06/12 22:47
Aurinia’s PRESERVE Trial: New Combination Strategy for Lupus Nephritis in Focus
TipRanks · 06/12 16:34
Weekly Report: what happened at AUPH last week (0601-0605)?
Weekly Report · 06/08 09:49
Aurinia Shareholders Back Board Slate and Governance Measures
TipRanks · 06/04 21:48
More
About AUPH
Aurinia Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. It has developed LUPKYNIS (voclosporin), an oral therapy for the treatment of adult patients with active lupus nephritis (LN) and continues to conduct clinical and regulatory activities to support the LUPKYNIS development program. The Company is also developing aritinercept (AUR200), a dual inhibitor of B cell-activating factor (BAFF) and a proliferation-inducing ligand (APRIL) for the potential treatment of autoimmune diseases. It sells LUPKYNIS to specialty pharmacies and a specialty distributor in the United States and sells LUPKYNIS inventory to its collaboration partner, Otsuka Pharmaceutical Co., Ltd. (Otsuka), for the European and Japanese market. The Company sells encapsulated voclosporin to its collaboration partner, Otsuka, which Otsuka then sells to customers in its territories.

Webull offers Aurinia Pharmaceuticals Inc stock information, including NASDAQ: AUPH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AUPH stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AUPH stock methods without spending real money on the virtual paper trading platform.